Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Three New/Expanded Collaborations in Holiday-Shortened Week

Week in Review: Fosun Signs $840 Million Deal for US Rights to Henlius' PD-1

Week in Review: Insilico Signs Six-Drug AI Discovery Deal with Sanofi Worth up to $1.2 Billion

Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex

Week in Review: VectorBuilder Raises $57 Million for Gene Therapy Delivery CDMO

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022